The company
Verrica Pharmaceuticals Inc.
VRCA · Nasdaq
VRCA stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 37.7% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 23
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $18.4M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 42 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John J. KirbyInterim CFO | bought | 5,000at $4.93 | 18 Aug 2026filed 18 Aug 2026 |
| Noah L. RosenbergCMO | bought | 2,030at $4.92 | 18 Aug 2026filed 18 Aug 2026 |
| Noah L. RosenbergCMO | bought | 4,200at $4.91 | 17 Aug 2026filed 18 Aug 2026 |
| Jayson RiegerCEO and President | bought | 5,000at $4.91 | 17 Aug 2026filed 18 Aug 2026 |
| David ZawitzChief Operating Officer | bought | 6,000at $4.98 | 17 Aug 2026filed 18 Aug 2026 |
| Jayson RiegerCEO and President | bought | 20,000at $5.06 | 14 Aug 2026filed 18 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Caligan Partners LPunchanged · filed 14 Aug 2026 | 923,910$5.7M | 00.0% |
| CANNELL CAPITAL LLCadded · filed 18 Aug 2026 | 783,923$4.8M | +98,800+14.4% |
| Affinity Asset Advisors, LLCunchanged · filed 13 Aug 2026 | 707,338$4.3M | 00.0% |
| Velan Capital Investment Management LPunchanged · filed 14 Aug 2026 | 471,559$2.9M | 00.0% |
| ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026 | 426,304$2.6M | -91,877−17.7% |
| BOOTHBAY FUND MANAGEMENT, LLCunchanged · filed 14 Aug 2026 | 280,734$1.7M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 279,310$1.7M | +90,552+48.0% |
| Mariner, LLCadded · filed 13 Aug 2026 | 207,230$1.3M | +182,686+744.3% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 138,160$846K | -757−0.5% |
| Stonepine Capital Management, LLCreduced · filed 14 Aug 2026 | 88,417$241K | -11,318−11.3% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.